Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
Castle Biosciences Inc (NASDAQ: CSTL) closed the day trading at $20.93 down -1.60% from the previous closing price of $21.27. In other words, the price has decreased by -$1.60 from its previous closing price. On the day, 0.57 million shares were traded. CSTL stock price reached its highest trading level at $21.865 during the session, while it also had its lowest trading level at $20.26.
Ratios:
For a better understanding of CSTL, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 2.06 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 13.97. For the most recent quarter (mrq), Quick Ratio is recorded 7.13 and its Current Ratio is at 7.29. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Guggenheim on December 14, 2023, initiated with a Buy rating and assigned the stock a target price of $25.
On January 05, 2023, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $54.
On January 07, 2022, Stephens started tracking the stock assigning a Overweight rating and target price of $59.Stephens initiated its Overweight rating on January 07, 2022, with a $59 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 21 ’25 when MAETZOLD DEREK J sold 4,408 shares for $21.52 per share. The transaction valued at 94,851 led to the insider holds 4,275 shares of the business.
MAETZOLD DEREK J sold 1,236 shares of CSTL for $26,596 on Apr 21 ’25. The Pres. & Chief Exec. Officer now owns 74,627 shares after completing the transaction at $21.52 per share. On Apr 09 ’25, another insider, MAETZOLD DEREK J, who serves as the Pres. & Chief Exec. Officer of the company, sold 3,647 shares for $20.22 each. As a result, the insider received 73,739 and left with 4,440 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CSTL now has a Market Capitalization of 603723776 and an Enterprise Value of 330115296. As of this moment, Castle’s Price-to-Earnings (P/E) ratio for their current fiscal year is 34.15. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.82 while its Price-to-Book (P/B) ratio in mrq is 1.31. Its current Enterprise Value per Revenue stands at 0.994 whereas that against EBITDA is 13.383.
Stock Price History:
The Beta on a monthly basis for CSTL is 1.14, which has changed by 0.029006839 over the last 52 weeks, in comparison to a change of 0.07545352 over the same period for the S&P500. Over the past 52 weeks, CSTL has reached a high of $35.84, while it has fallen to a 52-week low of $16.97. The 50-Day Moving Average of the stock is -3.19%, while the 200-Day Moving Average is calculated to be -21.14%.
Shares Statistics:
Over the past 3-months, CSTL traded about 409.42K shares per day on average, while over the past 10 days, CSTL traded about 414580 shares per day. A total of 28.48M shares are outstanding, with a floating share count of 27.97M. Insiders hold about 3.02% of the company’s shares, while institutions hold 98.50% stake in the company. Shares short for CSTL as of 1743379200 were 1671808 with a Short Ratio of 4.08, compared to 1740700800 on 1848788. Therefore, it implies a Short% of Shares Outstanding of 1671808 and a Short% of Float of 6.0399998.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
